The Food and Drug Administration (FDA) has approved the Senza Omnia Spinal Cord Stimulation (SCS) System (Nevro) for the treatment of chronic intractable pain of the trunk and/or limbs.
Apadaz (benzhydrocodone and acetaminophen immediate-release tablets) and its authorized generic AG-Apadaz will be available nationally beginning in November 2019.
Headache specialist was more likely to use triptans, while non-headache specialists and the headache specialist started prophylaxis at similar rates in eligible participants.
Off-label antidepressant use for chronic pain has increased in recent years in part as a result of the opioid epidemic and the need to reduce prescribing and use of opioids for chronic pain.
Revised criteria from the third edition of the International Classification of Headache Disorders (ICHD-3), can differentiate between chronic cluster headache (CCH) and episodic cluster headache (ECH) and may increase the number of CCH diagnoses.
The authors refute a systematic review and meta-analysis of literature on greater occipital nerve block for the treatment of chronic migraine headaches by Shauly and colleagues and published in Plastic and Reconstructive Surgery, citing extensive limitations and claiming the study ultimately raises more questions than answers.
Women with vs without frequent episodic tension-type headache (TTH) may have greater nerve sensitivity in response to mechanical stimuli, according to a study in Musculoskeletal Science and Practice. In this case-control, cross-sectional analysis, 32 consecutive women with TTH and 32 age-matched control individuals without a history of headache over the previous year were recruited from…
Patients who initially see a physical therapist or chiropractor for low back pain rather than a primary care physician are much less likely to be prescribed opioids.
